Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masakuni Furusato is active.

Publication


Featured researches published by Masakuni Furusato.


The American Journal of Surgical Pathology | 2005

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

Jonathan I. Epstein; William C. Allsbrook; Mahul B. Amin; Lars Egevad; Sheldon Bastacky; Antonio Lòpez Beltran; Aasmund Berner; Athanase Billis; Liliane Boccon-Gibod; Liang Cheng; Francisco Civantos; Cynthia Cohen; Michael B. Cohen; Milton W. Datta; Charles J. Davis; Brett Delahunt; Warick Delprado; John N. Eble; Christopher S. Foster; Masakuni Furusato; Paul B. Gaudin; David J. Grignon; Peter A. Humphrey; Kenneth A. Iczkowski; Edward C. Jones; Scott Lucia; Peter McCue; Tipu Nazeer; Esther Oliva; Chin Chen Pan

Five years after the last prostatic carcinoma grading consensus conference of the International Society of Urological Pathology (ISUP), accrual of new data and modification of clinical practice require an update of current pathologic grading guidelines. This manuscript summarizes the proceedings of the ISUP consensus meeting for grading of prostatic carcinoma held in September 2019, in Nice, France. Topics brought to consensus included the following: (1) approaches to reporting of Gleason patterns 4 and 5 quantities, and minor/tertiary patterns, (2) an agreement to report the presence of invasive cribriform carcinoma, (3) an agreement to incorporate intraductal carcinoma into grading, and (4) individual versus aggregate grading of systematic and multiparametric magnetic resonance imaging-targeted biopsies. Finally, developments in the field of artificial intelligence in the grading of prostatic carcinoma and future research perspectives were discussed.


The American Journal of Surgical Pathology | 1998

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder

Jonathan I. Epstein; Mahul B. Amin; Victor R. Reuter; F. K. Mostofi; Ferran Algaba; William C. Allsbrook; Alberto G. Ayala; Michael J. Becich; Antonio Lòpez Beltran; Lilliane Boccon-Gibód; David G. Bostwick; Christer Busch; Charles J. Davis; John N. Eble; Christopher S. Foster; Masakuni Furusato; David J. Grignon; Peter A. Humphrey; Elia A. Ishak; Sonny L. Johansson; Edward C. Jones; Leopold G. Koss; Howard S. Levin; William M. Murphy; Robert O. Petersen; Andrew A. Renshaw; Jae Y. Ro; Jeffrey R. Ross; Isabell A. Sesterhenn; John R. Srigley

In October 1997, Dr. F.K. Mostofi assembled a group of individuals interested in bladder neoplasia at a meeting in Washington DC. The participants included urologic pathologists, urologists, urologic oncologists, and basic scientists with an interest in bladder neoplasia. The purpose of this meeting was to discuss bladder terminology and make recommendations to the World Health Organization (WHO) Committee on urothelial tumors. Following this meeting, a group of the urologic pathologists who attended the Washington meeting decided to broaden the representation of the group and arranged a meeting primarily of the members of the International Society of Urologic Pathologists (ISUP) at the 1998 United States and Canadian Academy of Pathology Meeting held in Boston. Massachusetts. At this meeting. issues regarding terminology of bladder lesions, primarily neoplastic and putative preneoplastic lesions, were discussed, resulting in a consensus statement. The WHO/ ISUP consensus classification arises from this consensus conference committees recommendations to the WHO planning committee and their agreement with virtually all of the proposals presented herein. 29 The effort involved in reaching such a consensus was often considerable. Many of those involved in this process have compromised to arrive at a consensus. The aim was to develop a universally acceptable classification system for bladder neoplasia that could be used effectively by pathologists, urologists, and oncologists.


Laboratory Investigation | 2006

Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis.

Shin Wakui; Kiyofumi Yokoo; Tomoko Muto; Yoshihiko Suzuki; Hiroyuki Takahashi; Masakuni Furusato; Hiroshi Hano; Hitoshi Endou; Yoshikatsu Kanai

Endothelial cells and pericytes play critical role in angiogenesis, which is controlled, in part, by the angiopoietin (Ang)/Tie-2 system and vascular endothelial growth factor (VEGF). Here, we investigated Ang, Tie-2, and VEGF expression within endothelial cells and pericyte interdigitations (EPI), which consist of cytoplasmic projections of pericytes and corresponding endothelial indentations. After subcutaneous implantation of a thermoreversible gelation polymer disc in rats, the capillary density was low on day 5, increased to a peak on day 7, and then decreased on days 10–20. A small number of EPI were observed on day 5, then increased sharply to a peak on day 10, but had decreased on day 20. Light and electron microscopy immunohistochemical and RNA in situ hybridization analyses revealed that Tie-2 localized at endothelial cells, and Ang-2 localized at endothelial cells and pericytes, while Ang-1 and VEGF localized at pericytes, and Ang-1 was most intensely observed at EPI of pericytes. Conventional quantitative RT-PCR and Western blot analyses revealed that the level of Ang-1 was low on days 5–7, then increased on days 10–20, while the level of VEGF was high on days 5–10, but had decreased on day 20. The level of Ang-2 remained high and Tie-2 remained at the level of the control on days 5–20. The present study showed that the angiogenic phase might be initiated by increases in Ang-2 and VEGF, while the microvessel maturation phase might be initiated by a relative increase in Ang-1 and a decrease in VEGF. Moreover, EPI might serve as a pathway for the Ang-1/Tie-2 system, with VEGF promoting pericyte recruitment for microvascular integrity.


Journal of Obstetrics and Gynaecology Research | 1997

The Behavior of Endometrial Hyperplasia: A Prospective Study

Naoki Terakawa; Junzo Kigawa; Yuji Taketani; Hiroyuki Yoshikawa; Akira Yajima; Kiichiro Noda; Hiroji Okada; Junzo Kato; Michiaki Yakushiji; Osamu Tanizawa; Seiichiro Fujimoto; Shiro Nozawa; Takeshi Takahashi; Katsuhiko Hasumi; N. Furuhashi; Toshihiro Aono; Atsuhiko Sakamoto; Masakuni Furusato

Objective: To clarify the behavior of endometrial hyperplasia in a prospective study.


Pathology International | 1987

RENAL CELL CARCINOMA OF LOWER NEPHRON ORIGIN

Shigeo Aizawa; Yasushi Kikuchi; Masafumi Suzuki; Masakuni Furusato

Thirty‐four renal cell carcinomas, including 4 small tumors localized in the medulla were studied by means of histochemical and immunohistochemical methods using the markers for the lower nephron. Seven tumors had binding sites for soybean and peanut agglutinins and showed positive reactions to monoclonal antibodies to epithelial membrane antigen and cytokeratin. All these markers normally exist in the epithelial cells of distal and collecting tubules. There was no tumor from the thick ascending limb in our materials because of negative reaction to the monoclonal antibody against Tamm‐Horsfall protein. Also negative was to CEA, which means there was no adenocarcinoma of colonic metaplastic origin from the renal pelvic mucosa. There were two histologically different types of cancers derived from the lower nephron, papillotubular adenocarcinoma with partial transitional differentiation, and papillary adenocarcinoma. All seven patients were males, aged between 30 and 84 years. The prognosis was quite poor since all six patients with known follow‐up died of tumor.


Human Pathology | 2003

Accuracy of Gleason grading by practicing pathologists and the impact of education on improving agreement

Yoshiki Mikami; Toshiaki Manabe; Jonathan I. Epstein; Taizo Shiraishi; Masakuni Furusato; Toyonori Tsuzuki; Yoshihiro Matsuno; Hironobu Sasano

The aims of this study were to evaluate the accuracy of Gleason grading for prostatic adenocarcinoma among practicing pathologists in Japan and to determine the influence of education on this accuracy. Using a case-oriented approach, 16 hematoxylin and eosin-;stained glass slides with consensus scores established by 4 urologic pathologists were reviewed by 91 pathologists, divided into 2 groups. In group A, average agreements with consensus scores before and after an educational lecture were 55.7% (n = 17) and 68.4% (n = 25), and average kappa values were 0.43 and 0.67, respectively. Twelve pathologists reviewed slides twice in a different order, with average agreements of 59.5% and 77.6%, and average kappa values of 0.48 and 0.69 before and after the lecture, yielding a statistically significant improvement. In group B, the average agreement before providing an atlas with a tutorial was 61.3% (n = 61), and the kappa value was 0.44. In the second round, the average agreement was 74.5% (n = 39), and the kappa value was 0.68. Among 39 pathologists who reviewed slides twice, the average agreement in the first round was 58.8%, and the kappa value was 0.42. Improvement of both the average agreement and the kappa value were statistically significant. The average improvement in kappa values among participants who reviewed slides twice was 0.22 in group A and 0.27 in group B, a difference that is not statistically significant. Combining both groups, the incidence of concordant scores for 16 cases rose from 58.9% to 75.4%, an average increase of 16.5%. The undergrading of score 5-7 lesions was significantly reduced, from 36.3% to 14.2%. With respect to demographic factors, pathologists signing out more than 5000 cases per year showed a better agreement than those with more than 1000 cases per year (48.9% versus 78.8%; P = 0.031). These results indicate that the general agreement of Gleason scores among practicing pathologists in Japan was comparable with those in the Western countries as reported in the literature. Although this requires further improvement, both the lecture and the printed material had a similar influence on the degree of improvement.


Veterinary Pathology | 2000

p53 gene mutations occurring in spontaneous benign and malignant mammary tumors of the dog.

Tomoko Muto; Shin Wakui; Hiroyuki Takahashi; S. Maekawa; Toshio Masaoka; Shinichiro Ushigome; Masakuni Furusato

Sixty-three cases of benign and malignant canine mammary tumors were analyzed to define the alteration of exons 5–8 for the p53 tumor suppressor gene using polymerase chain reaction direct sequence analysis with paraffin-embedded tissues. Four missense mutations were found in 38 benign mammary tumors (11%), and five missense (one tumor had two missense mutations) and one nonsense mutations were found in 25 mammary carcinomas (20%). These data suggest that the p53 gene alterations might be initiated at an early stage of canine mammary carcinogenesis and p53 mutations might be associated with malignancy. However, there was no evidence of any relationship between the p53 alterations and the histologic types of tumors or breeds of dogs.


Cell and Tissue Research | 1977

Stereoscopic scanning electron microscopy of the red pulp of dog spleen with special reference to the terminal structure of the cordal capillaries

Teruo Suzuki; Masakuni Furusato; Satoshi Takasaki; Susumu Shimizu; Yoshiaki Hataba

SummaryIn order to obtain direct morphological information about the three-dimensional fine structure of the splenic terminal vascular bed, especially the terminating mode of the cordal capillaries, stereoscopic scanning electron microscopy of perfusion-fixed and freeze-fractured red pulp of a normal dog spleen was undertaken.An improved method of perfusion-fixation was utilized in which the hydrostatic pressures of the splenic artery and vein were maintained at approximately the same levels as those in the living state. Stereoscopic observations of scanning electron micrographs clearly demonstrated the three-dimensional fine architecture of the splenic sinuses, the spongy cordal reticular tissue and the intracordal vasculature.The cordal capillaries terminate in the labyrinthine cordal space according to a certain mode in which the walls of the terminals are transformed into a meshwork structure continuous with the cordal reticular tissue owing to an increase in number and size of fenestrations. No evidence could be detected to prove or suggest any direct continuity of the capillary end with the splenic sinus. These results strongly support the concept of an “open circulation”, at least in the red pulp of the dog spleen, with the possibility of a “functionally closed circulation” under some physiological conditions.


Pathology International | 2011

Immunohistochemical ETS-related gene detection in a Japanese prostate cancer cohort : Diagnostic use in Japanese prostate cancer patients

Bungo Furusato; Geert J.H.L. van Leenders; Jan Trapman; Takahiro Kimura; Shin Egawa; Hiroyuki Takahashi; Masakuni Furusato; Tapio Visakorpi; Hiroshi Hano

Chromosomal rearrangements that result in high expression levels of the ETS‐related gene (ERG) present in approximately 50% of prostate cancer (PCa) patients, making this one of the most common oncogenic alterations in PCa. However, ERG overexpression at the protein level has not been rigorously evaluated in Japanese PCa patients. In this study, we evaluated ERG expression using antibody‐based detection in 230 prostate specimens in a Japanese PCa cohort. Overall, we identified 20.1% ERG‐positive PCa cases. ERG was not detected in benign glands. The specificity of ERG staining for detecting PCa was almost 100%; all of the ERG‐positive samples were also diagnosed as PCa. The expression level of the ERG protein correlated with clinicopathological variables, including grade (P= 0.038), stage (P= 0.005), and metastatic status (P= 0.014). No correlation was observed with age (P= 0.196) or with preoperative prostate‐specific antigen level (P= 0.322). Although the frequency of ERG‐positive cases in Japanese PCa patients (20.1%) was lower than that reported in a PCa cohort in Western countries (approximately 50%), our study demonstrates that the clinical utility of ERG detection at the protein level can serve as an ancillary tool for diagnosing PCa in the Japanese population.


International Journal of Cancer | 2003

Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men

Hiroyuki Takahashi; Wei Lu; Masatoshi Watanabe; Takahiko Katoh; Masakuni Furusato; Hiromasa Tsukino; Hiroyuki Nakao; Akemi Sudo; Hiroyoshi Suzuki; Koichiro Akakura; Isao Ikemoto; Kouji Asano; Takaaki Ito; Shin Wakui; Tomoko Muto; Hiroshi Hano

The HPC2/ELAC2 gene may be associated with hereditary/familial prostate cancer (PCa). Two common missense variants (Ser217Leu and Ala541Thr) have been reported in the gene. We performed mutational, allelotyping and expression analyses and a molecular epidemiological study to clarify the relations between this gene and prostatic diseases, including PCa and benign prostatic hyperplasia (BPH) in Japanese men. We screened for mutations in 109 patients with PCa including 11 patients from 1 hereditary and 9 familial PCa. Loss of heterozygosity and expression were analyzed. An epidemiological study was done in sporadic PCa (n=98) and BPH (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2/ELAC2 gene. Somatic or germline mutations were not confirmed in any cases of PCa. Loss of heterozygosity at 2 microsatellites, D17S1289 and D17S520, was detected in 1 of 38 and 1 of 35 cases, respectively. Expression analysis revealed decreased or absent mRNA expression in 6 of 38 tumors. Epidemiologic analysis showed that a Leu allele at codon 217 was significantly more frequent in patients with PCa than in controls (10.2% vs. 3.5%, odds ratio = 3.11; 95% confidence interval, 1.22–7.90). At codon 541, all patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence interval, 0.94–7.13, not statistically significant). We concluded that germline/somatic mutations of HPC2/ELAC2 are uncommon in PCa. Similarly, allelic imbalances at the gene locus and changes in expression are rare. Although no difference in allele frequency at Ser217Leu between patients with PCa and controls has been reported in a Western population, this polymorphism is a potential indicator of PCa risk in Japanese men and it should be examined in other ethnic groups.

Collaboration


Dive into the Masakuni Furusato's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shigeo Aizawa

Jikei University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroshi Hano

Jikei University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Shinichiro Ushigome

Jikei University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takaaki Ito

Tokyo Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge